BackObalon Therapeutics Overview

Obalon Therapeutics Net Tangible Assets

Latest net tangible assets for OBLN: $9.3M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$9.34M

Peer average

Loading

Obalon Therapeutics Net Tangible Assets History

Loading

Obalon Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Obalon Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Obalon Therapeutics (OBLN) FAQ

Obalon Therapeutics (OBLN) currently reports a net tangible assets of $9.3M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Obalon Therapeutics's net tangible assets history and peer comparisons.

Obalon Therapeutics's net tangible assets changed from $0 to $9.3M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Obalon Therapeutics reported $9.3M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $9.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Obalon Therapeutics, and consider following OBLN for alerts when major investors trade the stock.

Obalon Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $9.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OBLN with unrelated industries.